By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Logical Therapeutics, Inc. 

300 Second Avenue

Waltham  Massachusetts  02451  U.S.A.
Phone: 781-290-0900 Fax: 781-290-0911



Company News
Logical Therapeutics, Inc. Secures $16.9M Series C Financing Round 5/27/2010 7:02:54 AM
Logical Therapeutics, Inc. Snags $10M to Make Pain Relievers Safer on the Gut 5/24/2010 7:25:00 AM
Logical Therapeutics, Inc. to Present Data on LT-NS001 at American College of Gastroenterology Annual Meeting 10/20/2009 11:42:57 AM
Logical Therapeutics, Inc. Appoints Peter A. Lankau as CEO and Director 5/11/2009 7:23:17 AM
Massachusetts Biotechnology Council, Inc. Release: 19 Biotech Companies Selected to Present at 10th Annual MassBio Investors Forum 12/2/2008 12:29:28 PM
Logical Therapeutics, Inc. Commences Double-Blind, Randomized Study of Their Lead Program, LT-NS001 9/8/2008 10:26:18 AM
Logical Therapeutics, Inc. Announces Results of Phase 1b Clinical Study of its Naproxen Prodrug 8/18/2008 7:27:28 AM
Logical Therapeutics, Inc. Co-Founder and CEO Honored with a Distinguished Investigator Award from the American College of Critical Care Medicine 2/8/2008 7:51:35 AM
Logical Therapeutics, Inc. In-Licenses Novel Anti-Inflammatory Drug 9/5/2006 12:25:36 PM
Logical Therapeutics, Inc. Launches Operations With Seed Capital From PA Early Stage Partners 8/10/2006 12:08:18 PM